{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T13:33:26Z","timestamp":1780925606422,"version":"3.54.1"},"reference-count":71,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.bbadis.2022.166430","type":"journal-article","created":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T00:32:06Z","timestamp":1652142726000},"page":"166430","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Trained immunity in viral infections, Alzheimer's disease and multiple sclerosis: A convergence in type I interferon signalling and IFN\u03b2-1a"],"prefix":"10.1016","volume":"1868","author":[{"given":"George D.","family":"Vavougios","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore","family":"Mavridis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artemios","family":"Artemiadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen A.","family":"Krogfelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Hadjigeorgiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2022.166430_bb0005","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awab337","article-title":"A genetic link between risk for Alzheimer's disease and severe COVID-19 outcomes via the OAS1 gene","author":"Magusali","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.bbadis.2022.166430_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.dscb.2021.100022","article-title":"FYN, SARS-CoV-2, and IFITM3 in the neurobiology of Alzheimer's disease","volume":"3","author":"Vavougios","year":"2021","journal-title":"Brain Disord."},{"key":"10.1016\/j.bbadis.2022.166430_bb0015","article-title":"Outside-in induction of the IFITM3 trafficking system by infections, including SARS-CoV-2, in the pathobiology of Alzheimer's disease","volume":"14","author":"Vavougios","year":"2021","journal-title":"Brain Behav. Immun. Health"},{"key":"10.1016\/j.bbadis.2022.166430_bb0020","doi-asserted-by":"crossref","DOI":"10.1002\/alz.12558","article-title":"Alzheimer's-like signaling in brains of COVID-19 patients","author":"Reiken","year":"2022","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.bbadis.2022.166430_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.639369","article-title":"Common peripheral immunity mechanisms in multiple sclerosis and Alzheimer's disease. Review","volume":"12","author":"Rossi","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbadis.2022.166430_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.742065","article-title":"Microglia in neuroinflammation and neurodegeneration: from understanding to therapy.Review","volume":"15","author":"Muzio","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.bbadis.2022.166430_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.758677","article-title":"Evaluating effects of glatiramer acetate treatment on amyloid deposition and tau phosphorylation in the 3xTg mouse model of Alzheimer's disease. Original research","volume":"15","author":"Dionisio-Santos","year":"2021","journal-title":"Front. Neurosci."},{"issue":"4","key":"10.1016\/j.bbadis.2022.166430_bb0040","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1172\/JCI133737","article-title":"Type I interferon response drives neuroinflammation and synapse loss in Alzheimer disease","volume":"130","author":"Roy","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2022.166430_bb0045","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.molimm.2020.08.021","article-title":"Double hit viral parasitism, polymicrobial CNS residency and perturbed proteostasis in Alzheimer's disease: a data driven, in silico analysis of gene expression data","volume":"127","author":"Vavougios","year":"2020","journal-title":"Mol. Immunol."},{"issue":"7868","key":"10.1016\/j.bbadis.2022.166430_bb0050","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41586-021-03710-0","article-title":"Dysregulation of brain and choroid plexus cell types in severe COVID-19","volume":"595","author":"Yang","year":"2021","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bbadis.2022.166430_bb0055","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13195-021-00850-3","article-title":"Network medicine links SARS-CoV-2\/COVID-19 infection to brain microvascular injury and neuroinflammation in dementia-like cognitive impairment","volume":"13","author":"Zhou","year":"2021","journal-title":"Alzheimers Res. Ther."},{"issue":"3","key":"10.1016\/j.bbadis.2022.166430_bb0060","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aay6324","article-title":"Microglia response following acute demyelination is heterogeneous and limits infiltrating macrophage dispersion","volume":"6","author":"Plemel","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bbadis.2022.166430_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcn.2021.103656","article-title":"An integrative study of genetic variants with brain tissue expression identifies viral etiology and potential drug targets of multiple sclerosis","volume":"115","author":"Manuel","year":"2021","journal-title":"Mol. Cell. Neurosci."},{"issue":"3","key":"10.1016\/j.bbadis.2022.166430_bb0070","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2020106501","article-title":"Opposing activities of IFITM proteins in SARS-CoV-2 infection","volume":"40","author":"Shi","year":"2021","journal-title":"Embo J."},{"issue":"7831","key":"10.1016\/j.bbadis.2022.166430_bb0075","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/s41586-020-2681-2","article-title":"The innate immunity protein IFITM3 modulates \u03b3-secretase in Alzheimer's disease","volume":"586","author":"Hur","year":"2020","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.bbadis.2022.166430_bb0080","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/sj.gene.6364324","article-title":"A subtype of multiple sclerosis defined by an activated immune defense program","volume":"7","author":"van Baarsen","year":"2006","journal-title":"Genes Immun."},{"issue":"5","key":"10.1016\/j.bbadis.2022.166430_bb0085","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1212\/WNL.0b013e3181ebdd2b","article-title":"OAS1: a multiple sclerosis susceptibility gene that influences disease severity","volume":"75","author":"O'Brien","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2022.166430_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.757249","article-title":"Type I interferon and the spectrum of susceptibility to viral infection and autoimmune disease: a shared genomic signature","volume":"12","author":"Sugrue","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bbadis.2022.166430_bb0095","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12974-019-1417-4","article-title":"Anti-inflammatory and cognitive effects of interferon-\u03b21a (IFN\u03b21a) in a rat model of Alzheimer's disease","volume":"16","author":"Mud\u00f2","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbadis.2022.166430_bb0100","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1016\/j.csbj.2020.11.048","article-title":"Genetic perturbation of IFN-\u03b1 transcriptional modulators in human endothelial cells uncovers pivotal regulators of angiogenesis","volume":"18","author":"Ciccarese","year":"2020","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"6552","key":"10.1016\/j.bbadis.2022.166430_bb0105","article-title":"Senolytics reduce coronavirus-related mortality in old mice","volume":"373","author":"Camell Christina","year":"2021","journal-title":"Science"},{"issue":"7831","key":"10.1016\/j.bbadis.2022.166430_bb0110","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/s41586-020-2681-2","article-title":"The innate immunity protein IFITM3 modulates \u03b3-secretase in Alzheimer's disease","volume":"586","author":"Hur","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2022.166430_bb0115","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.bbrc.2021.03.100","article-title":"SARS-CoV-2 spike protein interactions with amyloidogenic proteins: potential clues to neurodegeneration","volume":"554","author":"Idrees","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.bbadis.2022.166430_bb0120","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2018457118","article-title":"Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severity","volume":"118","author":"Ostkamp","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2022.166430_bb0125","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1016\/j.ijid.2019.02.029","article-title":"OAS1, OAS2 and OAS3 restrict intracellular M. tb replication and enhance cytokine secretion","volume":"80","author":"Leisching","year":"2019","journal-title":"Int. J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.bbadis.2022.166430_bb0130","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00439-011-1053-2","article-title":"Identification of a new susceptibility variant for multiple sclerosis in OAS1 by population genetics analysis","volume":"131","author":"Cagliani","year":"2012","journal-title":"Hum. Genet."},{"issue":"20","key":"10.1016\/j.bbadis.2022.166430_bb0135","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1093\/hmg\/ddt267","article-title":"Blood RNA profiling in a large cohort of multiple sclerosis patients and healthy controls","volume":"22","author":"Nickles","year":"2013","journal-title":"Hum. Mol. Genet."},{"issue":"13","key":"10.1016\/j.bbadis.2022.166430_bb0140","doi-asserted-by":"crossref","DOI":"10.1172\/JCI148517","article-title":"Nasal ciliated cells are primary targets for SARS-CoV-2 replication in the early stage of COVID-19","volume":"131","author":"Ahn","year":"2021","journal-title":"J. Clin. Invest."},{"issue":"18","key":"10.1016\/j.bbadis.2022.166430_bb0145","doi-asserted-by":"crossref","first-page":"4713","DOI":"10.1016\/j.cell.2021.07.023","article-title":"Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19","volume":"184","author":"Ziegler","year":"2021","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.bbadis.2022.166430_bb0150","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1093\/brain\/awab337","article-title":"A genetic link between risk for Alzheimer's disease and severe COVID-19 outcomes via the OAS1 gene","volume":"144","author":"Magusali","year":"2021","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.bbadis.2022.166430_bb0155","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12985-019-1146-4","article-title":"Anti-H7N9 avian influenza A virus activity of interferon in pseudostratified human airway epithelium cell cultures","volume":"16","author":"Chen","year":"2019","journal-title":"Virol. J."},{"issue":"5","key":"10.1016\/j.bbadis.2022.166430_bb0160","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.3390\/v7052618","article-title":"Insights into human astrocyte response to H5N1 infection by microarray analysis","volume":"7","author":"Lin","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.bbadis.2022.166430_bb0165","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/1372571","article-title":"Bioinformatics analysis of potential key genes in trastuzumab-resistant gastric cancer","volume":"2019","author":"Yang","year":"2019","journal-title":"Dis. Markers"},{"issue":"Pt 12","key":"10.1016\/j.bbadis.2022.166430_bb0170","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1099\/vir.0.013128-0","article-title":"Modulation of alpha interferon anti-hepatitis C virus activity by ISG15","volume":"90","author":"Chua","year":"2009","journal-title":"J. Gen. Virol."},{"issue":"12","key":"10.1016\/j.bbadis.2022.166430_bb0175","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1093\/infdis\/jiv321","article-title":"High anti-dengue virus activity of the OAS gene family is associated with increased severity of dengue","volume":"212","author":"Simon-Loriere","year":"2015","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.bbadis.2022.166430_bb0180","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.695738","article-title":"The hippocampal vulnerability to herpes simplex virus type I infection: relevance to Alzheimer\u2019s disease and memory impairment.Review","volume":"15","author":"Yong","year":"2021","journal-title":"Front. Cell. Neurosci."},{"issue":"6578","key":"10.1016\/j.bbadis.2022.166430_bb0185","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1126\/science.abj8222","article-title":"Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis","volume":"375","author":"Bjornevik","year":"2022","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.bbadis.2022.166430_bb0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006610","article-title":"Interference with the production of infectious viral particles and bimodal inhibition of replication are broadly conserved antiviral properties of IFITMs","volume":"13","author":"Tartour","year":"2017","journal-title":"PLoS Pathog."},{"issue":"3","key":"10.1016\/j.bbadis.2022.166430_bb0195","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s10517-017-3806-y","article-title":"Expression of IFN-inducible genes with antiviral function OAS1 and MX1 in health and under conditions of recurrent herpes simplex infection","volume":"163","author":"Karaulov","year":"2017","journal-title":"Bull. Exp. Biol. Med."},{"issue":"5","key":"10.1016\/j.bbadis.2022.166430_bb0200","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.stem.2020.01.017","article-title":"C\/EBP\u03b2-dependent epigenetic memory induces trained immunity in hematopoietic stem cells","volume":"26","author":"de Laval","year":"2020","journal-title":"Cell Stem Cell"},{"issue":"12","key":"10.1016\/j.bbadis.2022.166430_bb0205","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/j.jalz.2018.06.3040","article-title":"The antimicrobial protection hypothesis of Alzheimer's disease","volume":"14","author":"Moir","year":"2018","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.bbadis.2022.166430_bb0210","article-title":"Alzheimer's-like signaling in brains of COVID-19 patients","author":"Reiken","year":"32022","journal-title":"Alzheimers Dement."},{"issue":"1","key":"10.1016\/j.bbadis.2022.166430_bb0215","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1038\/s41467-017-01795-8","article-title":"HIV-1 counteracts an innate restriction by amyloid precursor protein resulting in neurodegeneration","volume":"8","author":"Chai","year":"2017","journal-title":"Nat.Commun."},{"issue":"39","key":"10.1016\/j.bbadis.2022.166430_bb0220","doi-asserted-by":"crossref","first-page":"E9162","DOI":"10.1073\/pnas.1720930115","article-title":"Interferon stimulation creates chromatin marks and establishes transcriptional memory","volume":"115","author":"Kamada","year":"2018","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbadis.2022.166430_bb0225","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.643650","article-title":"Long-term consequence of non-neurotropic H3N2 influenza A virus infection for the progression of Alzheimer's disease symptoms","volume":"15","author":"Hosseini","year":"2021","journal-title":"Front. Cell. Neurosci."},{"issue":"1","key":"10.1016\/j.bbadis.2022.166430_bb0230","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13195-021-00850-3","article-title":"Network medicine links SARS-CoV-2\/COVID-19 infection to brain microvascular injury and neuroinflammation in dementia-like cognitive impairment","volume":"13","author":"Zhou","year":"2021","journal-title":"Alzheimers Res. Ther."},{"issue":"1","key":"10.1016\/j.bbadis.2022.166430_bb0235","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1038\/s41598-020-59917-0","article-title":"Abrogation of type-I interferon signalling alters the microglial response to A\u03b21\u201342","volume":"10","author":"Moore","year":"2020","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.bbadis.2022.166430_bb0240","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1038\/cmi.2017.15","article-title":"IFITM3 inhibits virus-triggered induction of type I interferon by mediating autophagosome-dependent degradation of IRF3","volume":"15","author":"Jiang","year":"2018","journal-title":"Cell. Mol. Immunol."},{"issue":"1","key":"10.1016\/j.bbadis.2022.166430_bb0245","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12977-017-0377-y","article-title":"More than meets the I: the diverse antiviral and cellular functions of interferon-induced transmembrane proteins","volume":"14","author":"Shi","year":"2017","journal-title":"Retrovirology"},{"issue":"1","key":"10.1016\/j.bbadis.2022.166430_bb0250","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1089\/vim.2018.0085","article-title":"Type I interferons in NeuroHIV","volume":"32","author":"Thaney","year":"2019","journal-title":"Viral Immunol."},{"issue":"2","key":"10.1016\/j.bbadis.2022.166430_bb0255","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2174\/1570162X12666140526113544","article-title":"Cognitive consequences of a sustained monocyte type 1 IFN response in HIV-1 infection","volume":"12","author":"Pulliam","year":"2014","journal-title":"Curr. HIV Res."},{"issue":"6578","key":"10.1016\/j.bbadis.2022.166430_bb0260","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1126\/science.abj8222","article-title":"Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis","volume":"375","author":"Bjornevik","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2022.166430_bb0265","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.513383","article-title":"Epstein-Barr virus early protein BFRF1 suppresses IFN-\u03b2 activity by inhibiting the activation of IRF3. Original research","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbadis.2022.166430_bb0270","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.coviro.2016.01.001","article-title":"Type I interferons in viral control and immune regulation","volume":"16","author":"Teijaro","year":"2016","journal-title":"Curr. Opin. Virol."},{"issue":"Suppl 2","key":"10.1016\/j.bbadis.2022.166430_bb0275","doi-asserted-by":"crossref","first-page":"S369","DOI":"10.3233\/JAD-2010-100543","article-title":"Mitochondria and the link between neuroinflammation and neurodegeneration","volume":"20","author":"Di Filippo","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbadis.2022.166430_bb0280","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.729763","article-title":"Mitochondrial nucleic acid as a driver of pathogenic type I interferon induction in Mendelian disease. Mini review","volume":"12","author":"Lepelley","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbadis.2022.166430_bb0285","article-title":"Impact of COVID-19 on mitochondrial-based immunity in aging and age-related diseases","volume":"12","author":"Ganji","year":"2020","journal-title":"Front. Aging Neurosci."},{"issue":"340","key":"10.1016\/j.bbadis.2022.166430_bb0290","article-title":"Amyloid-\u03b2 peptide protects against microbial infection in mouse and worm models of Alzheimer's disease","volume":"8","author":"Kumar Deepak Kumar","year":"2016","journal-title":"Sci. Transl. Med."},{"issue":"6","key":"10.1016\/j.bbadis.2022.166430_bb0295","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41577-020-0285-6","article-title":"Defining trained immunity and its role in health and disease","volume":"20","author":"Netea","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.bbadis.2022.166430_bb0300","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1177\/1352458509350309","article-title":"Effects of immunomodulatory treatment with subcutaneous interferon beta-1a on cognitive decline in mildly disabled patients with relapsing-remitting multiple sclerosis","volume":"16","author":"Patti","year":"2010","journal-title":"Mult. Scler."},{"issue":"8","key":"10.1016\/j.bbadis.2022.166430_bb0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074111","article-title":"Subcutaneous interferon \u03b2-1a may protect against cognitive impairment in patients with relapsing-remitting multiple sclerosis: 5-year follow-up of the COGIMUS study","volume":"8","author":"Patti","year":"2013","journal-title":"PLoS One."},{"issue":"12","key":"10.1016\/j.bbadis.2022.166430_bb0310","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1007\/s00415-017-8642-5","article-title":"Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsing-remitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study)","volume":"264","author":"Comi","year":"2017","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.bbadis.2022.166430_bb0315","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1177\/1756285616671882","article-title":"Cognition and fatigue in patients with relapsing multiple sclerosis treated by subcutaneous interferon \u03b2-1a: an observational study SKORE","volume":"10","author":"Bene\u0161ov\u00e1","year":"2017","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"2","key":"10.1016\/j.bbadis.2022.166430_bb0320","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s40263-016-0401-0","article-title":"Effect on cognition of estroprogestins combined with interferon beta in multiple sclerosis: analysis of secondary outcomes from a randomised controlled trial","volume":"31","author":"De Giglio","year":"2017","journal-title":"CNS Drugs"},{"issue":"3","key":"10.1016\/j.bbadis.2022.166430_bb0325","first-page":"163","article-title":"Early treatment with high-dose interferon beta-1a reverses cognitive and cortical plasticity deficits in multiple sclerosis","volume":"27","author":"Mori","year":"2012","journal-title":"Funct. Neurol."},{"key":"10.1016\/j.bbadis.2022.166430_bb0330","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1742-2094-11-30","article-title":"A pilot study on the use of interferon beta-1a in early Alzheimer's disease subjects","volume":"11","author":"Grimaldi","year":"2014","journal-title":"J. Neuroinflammation"},{"issue":"2","key":"10.1016\/j.bbadis.2022.166430_bb0335","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3947\/ic.2021.0028","article-title":"Effects of interferon beta in COVID-19 adult patients: systematic review","volume":"53","author":"Sosa","year":"2021","journal-title":"Infect. Chemother."},{"issue":"4","key":"10.1016\/j.bbadis.2022.166430_bb0340","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1002\/jmv.27475","article-title":"Study of the effects of interferon \u03b2\u22121a on hospitalized patients with COVID-19: SBMU Taskforce on the COVIFERON study. doi:10.1002\/jmv.27475","volume":"94","author":"Fallahzadeh","year":"2022","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.bbadis.2022.166430_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103722","article-title":"Characterizing long COVID: deep phenotype of a complex condition","volume":"74","author":"Deer","year":"2021","journal-title":"EBioMedicine"},{"issue":"5","key":"10.1016\/j.bbadis.2022.166430_bb0350","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s00702-017-1745-4","article-title":"Type-I interferon pathway in neuroinflammation and neurodegeneration: focus on Alzheimer's disease","volume":"125","author":"Taylor","year":"2018","journal-title":"J. Neural Transm. (Vienna)"},{"issue":"8","key":"10.1016\/j.bbadis.2022.166430_bb0355","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1089\/jir.2013.0158","article-title":"How type I interferons work in multiple sclerosis and other diseases: some unexpected mechanisms","volume":"34","author":"Reder","year":"2014","journal-title":"J. Interf. Cytokine Res."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443922001004?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443922001004?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T05:09:07Z","timestamp":1760418547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443922001004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":71,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S0925443922001004"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2022.166430","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trained immunity in viral infections, Alzheimer's disease and multiple sclerosis: A convergence in type I interferon signalling and IFN\u03b2-1a","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2022.166430","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"166430"}}